The company will use the grant money to develop its resQ-RNA method, which is applicable to FFPE or degraded forensic samples.
The company, based in Constance, Germany, is launching three liquid biopsy assays as a research service this week that differ in target size and sensitivity.
The company's Confidence assays are designed to detect if a woman has a high-risk HPV subtype and, if so, determine her risk of developing cervical pre-cancer or cancer.
Evaluations of the test, which takes about 30 minutes to perform, demonstrated performance equivalent to a gold standard lab-based test.
The new test distinguishes Zika from other viruses in mosquito vectors and launches during an ongoing outbreak that has prompted new CDC guidelines.
In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.
A technology that has the potential to make species go extinct could be used against the Zika virus.
University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.
If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?